Enanta Pharmaceuticals
ENTA
$12.47
Share price
3.92%
Change (1 day)
-49.62%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Cash on Hand
Cash on Hand as of March 2024 : $0.30 B
According to Enanta Pharmaceuticals
's latest financial reports the company has $0.30 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-09-30 | $0.36 B | 48.42% |
| 2022-09-30 | $0.24 B | 2.14% |
| 2021-09-30 | $0.24 B | -36.89% |
| 2020-09-30 | $0.38 B | 15.34% |
| 2019-09-30 | $0.33 B | 8.59% |
| 2018-09-30 | $0.30 B | 38.03% |
| 2017-09-30 | $0.22 B | 6.47% |
| 2016-09-30 | $0.21 B | 44.68% |
| 2015-09-30 | $0.14 B | 59.98% |
| 2014-09-30 | $90.76 M | -10.56% |
| 2013-09-30 | $0.10 B | 131.89% |
| 2012-09-30 | $43.76 M | 87.59% |
| 2011-09-30 | $23.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 8,630.31% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 3,128.00% | 🇨🇭 Switzerland |
 AbbVie ABBV | $18.06 B | 5,916.78% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $10.17 B | 3,286.93% | 🇺🇸 USA |
 Merck MRK | $5.61 B | 1,771.07% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 3,120.01% | 🇺🇸 USA |